Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 39 results found. Search for [ AIOCD AWACS ]

Results 1 to 21 of 39
Joe C Mathew
August 11, 2020
The COVID crisis has impacted the Indian pharmaceutical market which grew just 0.2 per cent in July, even lower than the 2.4 per cent growth registered during June, the data showed


Joe C Mathew
March 13, 2020
Coronavirus update: Though the inventory level is down by eight days, there are sufficient stocks for more than a month for every therapeutic category


BusinessToday.In
New Delhi, November 7, 2019
Sun Pharma Q2 results: India sales, which accounted for 31.6 per cent of total consolidated sales, rose 35 per cent year-on-year (YoY) to Rs 2,515 crore in September quarter of this fiscal


Manu Kaushik
New Delhi, October 30, 2019
Even though Gangwal stands on thin ice if the powers entrusted in the shareholders' agreement are considered; Bhatia has much more to lose if this matter escalates further


PB Jayakumar
New Delhi, September 16, 2019
Since January, drug sales in the country were witnessing less than 10 per cent growth, mainly due to the increasing number of drugs coming under price control and inventory issues


BusinessToday.In
New Delhi, August 13, 2019
Sun Pharma Q1 results: Consolidated net sales grew 15.69 per cent to Rs 8,259.30 crore as against Rs 7,138.83 crore in the corresponding quarter; India sales, which accounted for 28 per cent of total sales, climbed 8 per cent YoY to Rs 2,314 crore in April-June period of this fiscal


PB Jayakumar
New Delhi, July 23, 2019
Normally, drug sales peak during the monsoon. This year, the onset of the monsoon got delayed in most parts of the country


BusinessToday.In
New Delhi, May 28, 2019
Sun Pharma's Q4 net profit declined to Rs 635.88 crore from Rs 1,342.50 crore in the same quarter last year; revenue from operations was at Rs 7,044.26 crore versus Rs 6,711.01 crore in Q4FY18


E Kumar Sharma
New Delhi, June 8, 2018
The Indian pharma has recently seen a perceptible slide in the number of new products hitting the market. According to the analysts, slippages are more in select therapies and they attribute this to several reasons.


Joe C Mathew
December 18, 2017
The court's observation came during a hearing that challenged a Delhi High Court order that had quashed the government ban on technical grounds.


Joe C Mathew
New Delhi, July 11, 2017
Sluggish medicine sales marked the first week of the Goods and Services Tax (GST) regime, as per the weekly update of the market research firm AIOCD-AWACS.


Joe C Mathew
New Delhi, June 27, 2017
A recent update by the market intelligence firm AIOCD-AWACS indicates that the inventory of medicines at the trade level was holding steady as on June 21.


P. B. Jayakumar
Delhi, May 1, 2017
At a time when Big Pharma is desperate for blockbuster breakthroughs and viable business strategies, one Indian firm is basking in the knowledge that its leadership baton will be passing into younger hands.


By Joe C. Mathew
Delhi, March 20, 2017
In spite of favourable court verdicts, top pharmaceutical companies are losing enthusiasm for fixed dose combination medicines.


By Joe C. Mathew
December 1, 2016
For the first time since the Narendra Modi government announced the demonetisation of Rs 500 and Rs 1,000 currency notes, medicine sales have indicated a sharp dip, suggests an analysis of secondary sales trends by market intelligence firm AIOCD AWACS.


By E Kumar Sharma
November 27, 2016
Demonetisation has had another side effect - patients are stocking up medicines for the next two to three months. This is especially so for ailments where life-long mediations are required such as for diabetes or hypertension - called chronic therapy areas in medical lingo.


By E. Kumar Sharma
Delhi, November 26, 2016
Sale of online prescription drugs could be great news for the customer, but monitoring e-pharmacies effectively will be a challenge.


By E. Kumar Sharma,E Kumar Sharma
Delhi, October 29, 2016
Many major pharma stocks, seen as safe bets in the worst of times, have seen their market caps slip in the past year. Is pharma losing its sheen on the bourses?


By Joe C. Mathew
Delhi, October 5, 2016
One of the earliest diagnoses made by Sun Pharma in the run-up to the Ranbaxy acquisition was that since the entire management was focusing on resolving the US FDA's negative observations, there was a lack of focus towards expanding the business.


E Kumar Sharma
September 2, 2016
Then, there was also a time, we would read about aging film actors getting a Botox treatment to get their wrinkles removed. But this is available more easily now.


PAGES 1 OF 2  12